S. Korean Drug Ministry minimizes steps for biologic agent imports,

The ministry has also introduced a legal basis to allow drug developers to skip phase 3 clinical trials for orphan drugs used to treat a rare disease or …, The ministry has also introduced a legal basis to allow drug developers to skip phase 3 clinical trials for orphan drugs used to treat a rare disease or …, Read More

Scroll to Top